| 1 | Colorectal Neoplasms | 68.7% |
| 2 | Cecal Neoplasms | 64% |
| 3 | Zollinger-Ellison syndrome | 59.1% |
| 4 | Appendiceal Neoplasms | 47.6% |
| 5 | Colonic Neoplasms | 47.6% |
| 6 | Rectal Neoplasms | 47.6% |
| 7 | Stomach Neoplasms | 45% |
| 8 | Adenomatous Polyposis Coli | 44% |
| 9 | Anus Neoplasms | 43.8% |
| 10 | Sigmoid Neoplasms | 43.8% |
| 11 | Duodenitis | 43.5% |
| 12 | Erosive Duodenitis | 43.5% |
| 13 | Esophageal Neoplasms | 43.1% |
| 14 | Duodenal Obstruction | 40.5% |
| 15 | Dysentery | 39% |
| 16 | Enteritis | 39% |
| 17 | Enterocolitis | 39% |
| 18 | Inflammatory Bowel Diseases | 39% |
| 19 | Proctocolitis | 38.8% |
| 20 | Duodenogastric Reflux | 37.9% |
| 21 | Peptic Ulcer | 37.9% |
| 22 | Ileitis | 37% |
| 23 | Mesenteric vascular insufficiency | 30.6% |
| 24 | Colitis | 30.5% |
| 25 | Proctitis | 30.5% |
| 26 | Intestinal Atresia | 30.4% |
| 27 | Mesenteric Vascular Occlusion | 30.4% |
| 28 | Intestinal Fistula | 30.3% |
| 29 | Enterocutaneous Fistula | 30.3% |
| 30 | Rectal Fistula | 30.1% |
| 31 | Anal Fistula | 30.1% |
| 32 | Gastrointestinal Stromal Tumors | 29.8% |
| 33 | Cecal Diseases | 29.1% |
| 34 | Colonic Diseases | 29.1% |
| 35 | Ileal Diseases | 29.1% |
| 36 | Intestinal Obstruction | 29.1% |
| 37 | Intestinal Perforation | 29.1% |
| 38 | Jejunal Diseases | 29.1% |
| 39 | Pneumatosis Cystoides Intestinalis | 29.1% |
| 40 | Rectal Diseases | 29.1% |
| 41 | Cronkhite-Canada Syndrome | 29.1% |
| 42 | Intestinal Polyposis | 29.1% |
| 43 | Liver neoplasms | 28% |
| 44 | Esophagitis | 27.8% |
| 45 | Gastritis | 27.8% |
| 46 | Peritoneal Neoplasms | 27.6% |
| 47 | Pouchitis | 27.6% |
| 48 | Esophageal Diseases | 27.2% |
| 49 | Gastroenteritis | 27.2% |
| 50 | Stomach Diseases | 27.2% |
| 51 | Duodenal Ulcer | 27.1% |
| 52 | Peptic Ulcer Perforation | 27.1% |
| 53 | Gastric ulcer | 27.1% |
| 54 | Appendicitis | 26.8% |
| 55 | Intestinal Diseases, Parasitic | 25.8% |
| 56 | Crohn Disease | 25.7% |
| 57 | Enterocolitis, Neutropenic | 25.7% |
| 58 | Necrotizing Enterocolitis | 25.7% |
| 59 | Pancreatic Neoplasm | 25% |
| 60 | Gastrointestinal Hemorrhage | 23.4% |
| 61 | Tuberculosis, Gastrointestinal | 23.2% |
| 62 | Intestinal Neoplasms | 22.8% |
| 63 | Colonic Pseudo-Obstruction | 22.6% |
| 64 | Enterocolitis, Pseudomembranous | 22.5% |
| 65 | pseudomembranous colitis | 22.5% |
| 66 | Dysentery, Bacillary | 22.5% |
| 67 | Superior Mesenteric Artery Syndrome | 20.9% |
| 68 | Gastrointestinal Neoplasms | 20.7% |
| 69 | Duodenal Neoplasms | 20.6% |
| 70 | Esophageal Atresia | 20.5% |
| 71 | Biliary Tract Diseases | 20.1% |
| 72 | Liver diseases | 20.1% |
| 73 | Pancreatic Diseases | 20.1% |
| 74 | Esophageal and Gastric Varices | 19.5% |
| 75 | Colonic Diseases, Functional | 19.3% |
| 76 | Fecal Incontinence | 19.3% |
| 77 | Fecal Impaction | 19.3% |
| 78 | Intussusception | 19.3% |
| 79 | Megacolon | 19.3% |
| 80 | Ileus | 19.3% |
| 81 | Meconium ileus | 19.3% |
| 82 | Colitis, Ischemic | 19.1% |
| 83 | Bile Duct Neoplasms | 19% |
| 84 | gallbladder neoplasm | 19% |
| 85 | Hemorrhoids | 16.8% |
| 86 | Afferent Loop Syndrome | 16.6% |
| 87 | Celiac Disease | 16.6% |
| 88 | Short Bowel Syndrome | 16.6% |
| 89 | Sprue, Tropical | 16.6% |
| 90 | Steatorrhea | 16.6% |
| 91 | Rectocele | 16.6% |
| 92 | Sprue | 16.6% |
| 93 | Rectal Prolapse | 16.6% |
| 94 | Pancreatic Fistula | 16.5% |
| 95 | Esophageal Stenosis | 16.2% |
| 96 | Gastric Dilatation | 16.2% |
| 97 | Gastric outlet obstruction | 16.2% |
| 98 | Barrett Esophagus | 16.2% |
| 99 | Hepatocellular Adenoma | 15.1% |
| 100 | Giardiasis | 14.8% |
| 101 | Liver Neoplasms, Experimental | 14.7% |
| 102 | Peutz-Jeghers Syndrome | 14.7% |
| 103 | Anal Fissure | 14.4% |
| 104 | Intestinal Pseudo-Obstruction | 14.4% |
| 105 | Irritable Bowel Syndrome | 14.4% |
| 106 | Neurogenic Bowel | 14.4% |
| 107 | Anal Ulcer | 14.4% |
| 108 | Esophageal Perforation | 14.3% |
| 109 | Deglutition Disorders | 14.1% |
| 110 | Achlorhydria | 13.9% |
| 111 | Gastric Antral Vascular Ectasia | 13.9% |
| 112 | Peptic Ulcer Hemorrhage | 13.9% |
| 113 | Gastroparesis | 13.9% |
| 114 | Choledochal Cyst | 13.4% |
| 115 | Digestive System Neoplasms | 13% |
| 116 | Lactose Intolerance | 12.9% |
| 117 | Carcinoma, Pancreatic Ductal | 12.6% |
| 118 | Pruritus Ani | 12.4% |
| 119 | Melena | 12.3% |
| 120 | Biliary cirrhosis | 12.1% |
| 121 | Hematemesis | 12.1% |
| 122 | Pancreatic Cyst | 11.6% |
| 123 | Cholecystolithiasis | 11.1% |
| 124 | Bile Duct Diseases | 10.9% |
| 125 | Cholelithiasis | 10.9% |
| 126 | Chylous Ascites | 10.9% |
| 127 | Fatty Liver | 10.9% |
| 128 | Hepatitis | 10.9% |
| 129 | Portal Hypertension | 10.9% |
| 130 | Intestinal Diseases | 10.9% |
| 131 | Liver Cirrhosis | 10.9% |
| 132 | Pancreatic Insufficiency | 10.9% |
| 133 | Pancreatitis | 10.9% |
| 134 | Pneumoperitoneum | 10.9% |
| 135 | Focal Nodular Hyperplasia | 10.9% |
| 136 | Hepatic Insufficiency | 10.9% |
| 137 | Steatohepatitis | 10.9% |
| 138 | Cryptosporidiosis | 10.8% |
| 139 | Esophageal motility disorders | 10.7% |
| 140 | Mallory-Weiss Syndrome | 10.7% |
| 141 | Pyloric Stenosis | 10.7% |
| 142 | Fatty Liver, Alcoholic | 9.7% |
| 143 | Hepatitis, Alcoholic | 9.7% |
| 144 | Liver Cirrhosis, Alcoholic | 9.7% |
| 145 | Liver Diseases, Parasitic | 9.6% |
| 146 | Hepatic Veno-Occlusive Disease | 9.5% |
| 147 | Peliosis Hepatis | 9.5% |
| 148 | Hepatopulmonary Syndrome | 9.5% |
| 149 | Anus, Imperforate | 9.4% |
| 150 | Hemoperitoneum | 9.4% |
| 151 | Hepatomegaly | 9.4% |
| 152 | Mesenteric Panniculitis | 9.4% |
| 153 | Panniculitis, Peritoneal | 9.4% |
| 154 | Peritonitis | 9.4% |
| 155 | Peritoneal Fibrosis | 9.4% |
| 156 | Encapsulating Peritoneal Sclerosis | 9.4% |
| 157 | Anorectal Malformations | 9.4% |
| 158 | Biliary Fistula | 9.3% |
| 159 | Gastric Fistula | 9.3% |
| 160 | Hepatic Vein Thrombosis | 9.3% |
| 161 | Liver Abscess | 9.3% |
| 162 | Budd-Chiari Syndrome | 9.3% |
| 163 | Choledocholithiasis | 9.2% |
| 164 | Diverticulitis | 9.2% |
| 165 | Dumping Syndrome | 9.2% |
| 166 | insulinoma | 9% |
| 167 | Gastrinoma | 9% |
| 168 | Glucagonoma | 9% |
| 169 | Vipoma | 8.4% |
| 170 | Chemical and Drug Induced Liver Injury | 8.4% |
| 171 | Hepatorenal Syndrome | 8.2% |
| 172 | Diverticulum | 8.1% |
| 173 | Diverticulosis | 8.1% |
| 174 | Esophageal Achalasia | 8% |
| 175 | Liver Abscess, Amebic | 7.9% |
| 176 | Cystic Fibrosis | 7.5% |
| 177 | Abdominal Neoplasms | 7.4% |
| 178 | Head and Neck Neoplasms | 7.4% |
| 179 | Soft Tissue Neoplasms | 7.4% |
| 180 | Thoracic Neoplasms | 7.4% |
| 181 | Porphyrias, Hepatic | 7.3% |
| 182 | Congenital Hyperinsulinism | 7.3% |
| 183 | Pancreatic Pseudocyst | 6.7% |
| 184 | Endocrine Gland Neoplasms | 6.5% |
| 185 | Eye Neoplasms | 6.5% |
| 186 | Nervous System Neoplasms | 6.5% |
| 187 | Cholangitis | 6.5% |
| 188 | Cholecystitis | 6.5% |
| 189 | Cholestasis | 6.5% |
| 190 | Common Bile Duct Diseases | 6.5% |
| 191 | Hepatitis, Chronic | 6.5% |
| 192 | Liver Failure | 6.5% |
| 193 | Pancreatitis, Chronic | 6.5% |
| 194 | Non-alcoholic Fatty Liver Disease | 6.5% |
| 195 | Chronic active hepatitis | 6.5% |
| 196 | Bone neoplasms | 6.4% |
| 197 | Skin Neoplasms | 6.4% |
| 198 | Hematologic Neoplasms | 6.4% |
| 199 | Splenic Neoplasms | 6.3% |
| 200 | Laryngopharyngeal Reflux | 5.8% |
| 201 | Hepatitis, Animal | 5.7% |
| 202 | Hepatitis, Viral, Human | 5.7% |
| 203 | Liver Cirrhosis, Experimental | 5.6% |
| 204 | Pancreatitis, Alcoholic | 5.5% |
| 205 | Parathyroid Neoplasms | 5.5% |
| 206 | Thyroid Neoplasm | 5.5% |
| 207 | Thyroid carcinoma | 5.5% |
| 208 | Multiple Endocrine Neoplasia | 5.5% |
| 209 | Hepatitis B, Chronic | 5% |
| 210 | Hepatitis C, Chronic | 5% |
| 211 | Gastrointestinal Diseases | 5% |
| 212 | Paraneoplastic Encephalomyelitis | 5% |
| 213 | Fascioliasis | 4.9% |
| 214 | Echinococcosis, Hepatic | 4.9% |
| 215 | Mammary Neoplasms, Experimental | 4.9% |
| 216 | Chemical and Drug Induced Liver Injury, Chronic | 4.9% |
| 217 | Reye Syndrome | 4.9% |
| 218 | Hamartoma | 4.7% |
| 219 | Neoplasms, Hormone-Dependent | 4.7% |
| 220 | Neoplasms, Multiple Primary | 4.7% |
| 221 | Paraneoplastic Syndromes | 4.7% |
| 222 | Precancerous Conditions | 4.7% |
| 223 | Neoplasms, Second Primary | 4.7% |
| 224 | Tracheal Neoplasms | 4.4% |
| 225 | CREST Syndrome | 4.4% |
| 226 | Zellweger Syndrome | 4.3% |
| 227 | Nesidioblastosis | 4.3% |
| 228 | Variegate Porphyria | 4.3% |
| 229 | Acute intermittent porphyria | 4.3% |
| 230 | Porphyria Cutanea Tarda | 4.3% |
| 231 | Cholestasis, Extrahepatic | 4.3% |
| 232 | Biliary Dyskinesia | 4.3% |
| 233 | Cholangitis, Sclerosing | 4.3% |
| 234 | Liver Failure, Acute | 4.3% |
| 235 | Acalculous Cholecystitis | 4.3% |
| 236 | End Stage Liver Disease | 4.3% |
| 237 | Acanthoma | 4.2% |
| 238 | Cyst | 4.1% |
| 239 | Neoplastic Processes | 4.1% |
| 240 | Neoplastic Syndromes, Hereditary | 4.1% |
| 241 | Pregnancy Complications, Neoplastic | 4.1% |
| 242 | Hepatolenticular Degeneration | 4.1% |
| 243 | Neoplasms, Experimental | 4.1% |
| 244 | Retroperitoneal Neoplasms | 4% |
| 245 | Autoimmune hepatitis | 3.7% |
| 246 | Testicular Neoplasms | 3.6% |
| 247 | Carcinoma, Lobular | 3.6% |
| 248 | Neoplasms, Radiation-Induced | 3.6% |
| 249 | Mouth Neoplasms | 3.5% |
| 250 | Central Nervous System Neoplasms | 3.5% |
| 251 | Vascular Neoplasms | 3.5% |
| 252 | Thymus Neoplasms | 3.5% |
| 253 | Genital Neoplasms, Female | 3.5% |
| 254 | Breast Neoplasms, Male | 3.5% |
| 255 | Triple Negative Breast Neoplasms | 3.5% |
| 256 | Hepatitis, Viral, Animal | 3.4% |
| 257 | Hepatitis E | 3.3% |
| 258 | Hepatitis B | 3.3% |
| 259 | Hepatitis C | 3.3% |
| 260 | Hepatitis A | 3.3% |
| 261 | Thyroid Nodule | 3.2% |
| 262 | Hepatic Encephalopathy | 3.2% |
| 263 | Tuberous Sclerosis | 3.2% |
| 264 | Massive Hepatic Necrosis | 3.2% |
| 265 | Emphysematous Cholecystitis | 3.2% |
| 266 | Sphincter of Oddi Dysfunction | 3.2% |
| 267 | Adrenal Gland Neoplasms | 3.1% |
| 268 | Genital Neoplasms, Male | 3.1% |
| 269 | Uveal Neoplasms | 3.1% |
| 270 | Multiple Endocrine Neoplasia Type 1 | 3.1% |
| 271 | Urologic Neoplasms | 3.1% |
| 272 | Sebaceous Gland Neoplasms | 3.1% |
| 273 | Spinal Neoplasms | 3.1% |
| 274 | Bone Marrow Neoplasms | 3.1% |
| 275 | Meningioma | 2.9% |
| 276 | Trophoblastic Neoplasms | 2.9% |
| 277 | Leukemia, Experimental | 2.9% |
| 278 | Carcinoma 256, Walker | 2.8% |
| 279 | Thymoma | 2.8% |
| 280 | Carcinoma, Ehrlich Tumor | 2.8% |
| 281 | Dermoid Cyst | 2.8% |
| 282 | Carcinoma, Lewis Lung | 2.8% |
| 283 | Leukemia, Radiation-Induced | 2.6% |
| 284 | Leukoplakia, Oral | 2.5% |
| 285 | Paraneoplastic Cerebellar Degeneration | 2.5% |
| 286 | Nephroblastoma | 2.5% |
| 287 | Nose Neoplasms | 2.5% |
| 288 | Erythroplasia | 2.5% |
| 289 | Follicular cyst | 2.5% |
| 290 | leukemia | 2.5% |
| 291 | Mucocele | 2.5% |
| 292 | Neoplasms, Germ Cell and Embryonal | 2.5% |
| 293 | Neoplasms, Glandular and Epithelial | 2.5% |
| 294 | Pilonidal Cyst | 2.5% |
| 295 | Thyroglossal Cyst | 2.5% |
| 296 | Synovial Cyst | 2.5% |
| 297 | Germ Cell Cancer | 2.5% |
| 298 | Aberrant Crypt Foci | 2.5% |
| 299 | ovarian neoplasm | 2.5% |
| 300 | Sarcoma, Experimental | 2.4% |
| 301 | Melanoma, Experimental | 2.4% |
| 302 | Pituitary Adenoma | 2.3% |
| 303 | Pituitary Neoplasms | 2.3% |
| 304 | Neuroectodermal Tumors | 2.3% |
| 305 | Limbic Encephalitis | 2.3% |
| 306 | Acoustic Neuroma | 2.3% |
| 307 | Neoplasms, Neuroepithelial | 2.2% |
| 308 | Gliomatosis cerebri | 2.2% |
| 309 | Palatal Neoplasms | 2.2% |
| 310 | Retinoblastoma | 2.2% |
| 311 | Leukoplakia | 2.1% |
| 312 | Lymphocele | 2.1% |
| 313 | Breast Cyst | 2.1% |
| 314 | Histiocytic Disorders, Malignant | 2.1% |
| 315 | Actinic keratosis | 2.1% |
| 316 | Mediastinal Cyst | 2.1% |
| 317 | Neoplasm Invasiveness | 2.1% |
| 318 | Neoplasm Metastasis | 2.1% |
| 319 | Neoplasm Recurrence, Local | 2.1% |
| 320 | Parovarian Cyst | 2.1% |
| 321 | Pericardial Cyst | 2.1% |
| 322 | Thymic Cyst | 2.1% |
| 323 | Carcinogenesis | 2.1% |
| 324 | Myxoid cyst | 2.1% |
| 325 | Metastasis | 2.1% |
| 326 | Lambert-Eaton Myasthenic Syndrome | 2.1% |
| 327 | Meningeal Neoplasms | 2.1% |
| 328 | Lymphomatoid Granulomatosis | 2% |
| 329 | Prolactinoma | 1.9% |
| 330 | Growth Hormone-Secreting Pituitary Adenoma | 1.9% |
| 331 | Opsoclonus-Myoclonus Syndrome | 1.9% |
| 332 | Ear Neoplasms | 1.9% |
| 333 | Eyelid Neoplasms | 1.9% |
| 334 | Lung Neoplasms | 1.9% |
| 335 | Pleural Neoplasms | 1.9% |
| 336 | Lymphoma | 1.8% |
| 337 | Carcinosarcoma | 1.8% |
| 338 | Hemangiosarcoma | 1.8% |
| 339 | Leukemia L1210 | 1.8% |
| 340 | Leukemia P388 | 1.8% |
| 341 | lymphangiosarcoma | 1.8% |
| 342 | Corpus Luteum Cyst | 1.8% |
| 343 | Ovarian Cysts | 1.8% |
| 344 | Brain Neoplasms | 1.8% |
| 345 | Salivary Gland Neoplasms | 1.8% |
| 346 | Spinal Cord Neoplasms | 1.8% |
| 347 | Tongue Neoplasms | 1.8% |
| 348 | melanoma | 1.8% |
| 349 | Uterine Neoplasms | 1.8% |
| 350 | Vaginal Neoplasms | 1.8% |
| 351 | Vulvar Neoplasms | 1.8% |
| 352 | Uterine Cancer | 1.8% |
| 353 | Fallopian Tube Neoplasms | 1.8% |
| 354 | Rift Valley Fever | 1.8% |
| 355 | Composite Lymphoma | 1.8% |
| 356 | Choriocarcinoma | 1.8% |
| 357 | granulosa cell tumor | 1.8% |
| 358 | Carcinoma, Ovarian Epithelial | 1.8% |
| 359 | Myelitis, Transverse | 1.8% |
| 360 | Basal Cell Nevus Syndrome | 1.7% |
| 361 | Pharyngeal Neoplasms | 1.7% |
| 362 | Leydig Cell Tumor | 1.7% |
| 363 | Optic Nerve Glioma | 1.7% |
| 364 | Central Nervous System Cysts | 1.6% |
| 365 | Penile Neoplasms | 1.6% |
| 366 | Prostatic Neoplasms | 1.6% |
| 367 | Leukemia, Plasma Cell | 1.6% |
| 368 | Sarcoma 180 | 1.6% |
| 369 | Polycythemia Vera | 1.6% |
| 370 | Mesoblastic Nephroma | 1.6% |
| 371 | Laryngeal neoplasm | 1.5% |
| 372 | Bladder Neoplasm | 1.5% |
| 373 | Kidney Neoplasm | 1.5% |
| 374 | Ureteral Neoplasms | 1.5% |
| 375 | Urethral Neoplasms | 1.5% |
| 376 | Medulloblastoma | 1.4% |
| 377 | Adenoma, Acidophil | 1.4% |
| 378 | Ganglioneuroma | 1.4% |
| 379 | Glioma | 1.4% |
| 380 | Malignant Glioma | 1.4% |
| 381 | Basal cell carcinoma | 1.4% |
| 382 | Carcinoma, Papillary | 1.4% |
| 383 | Squamous cell carcinoma | 1.4% |
| 384 | Chondrosarcoma | 1.4% |
| 385 | Craniopharyngioma | 1.4% |
| 386 | Cystadenoma | 1.4% |
| 387 | leiomyosarcoma | 1.4% |
| 388 | liposarcoma | 1.4% |
| 389 | Mesothelioma | 1.4% |
| 390 | synovial sarcoma | 1.4% |
| 391 | Neuroectodermal Tumor, Melanotic | 1.4% |
| 392 | Angiomyolipoma | 1.4% |
| 393 | Clear Cell Sarcoma of Soft Tissue | 1.4% |
| 394 | Alveolar Soft Part Sarcoma | 1.4% |
| 395 | Neuroendocrine Tumors | 1.4% |
| 396 | Sarcoma, Myeloid | 1.4% |
| 397 | Carcinoma, Basal Cell | 1.4% |
| 398 | Meningeal Carcinomatosis | 1.4% |
| 399 | Adenoma | 1.3% |
| 400 | Ameloblastoma | 1.3% |
| 401 | Angiokeratoma | 1.3% |
| 402 | Carcinoma | 1.3% |
| 403 | Chordoma | 1.3% |
| 404 | Hemangioma | 1.3% |
| 405 | hemangiopericytoma | 1.3% |
| 406 | Lymphangioma | 1.3% |
| 407 | Mesenchymoma | 1.3% |
| 408 | Nevus | 1.3% |
| 409 | Teratoma | 1.3% |
| 410 | Hepatoblastoma | 1.3% |
| 411 | Mixed Tumor, Mullerian | 1.3% |
| 412 | Germinoma | 1.3% |
| 413 | Teratocarcinoma | 1.3% |
| 414 | Angiofibroma | 1.3% |
| 415 | Sarcoma | 1.3% |
| 416 | Epithelioma | 1.3% |
| 417 | Adrenocortical carcinoma | 1.3% |
| 418 | Endometrial Stromal Sarcoma | 1.2% |
| 419 | Bronchial Neoplasms | 1.2% |
| 420 | Multiple Pulmonary Nodules | 1.2% |
| 421 | Supratentorial Neoplasms | 1.2% |
| 422 | Carcinoid Tumor | 1.2% |
| 423 | Endometrial Neoplasms | 1.2% |
| 424 | Neurilemmoma | 1.2% |
| 425 | Hutchinson's Melanotic Freckle | 1.2% |
| 426 | Melanoma, Amelanotic | 1.2% |
| 427 | Denys-Drash Syndrome | 1.2% |
| 428 | Renal Cell Carcinoma | 1.2% |
| 429 | Papillary Renal Cell Carcinoma | 1.2% |
| 430 | Plasmacytoma | 1.2% |
| 431 | Malignant histiocytosis | 1.2% |
| 432 | Lymphatic Metastasis | 1.2% |
| 433 | Neoplasms, Unknown Primary | 1.2% |
| 434 | Leukemic Infiltration | 1.2% |
| 435 | Histiocytic sarcoma | 1.2% |
| 436 | Neoplasm Micrometastasis | 1.2% |
| 437 | Cystadenocarcinoma | 1.1% |
| 438 | Fibrosarcoma | 1.1% |
| 439 | Osteosarcoma | 1.1% |
| 440 | Mucoepidermoid Carcinoma | 1.1% |
| 441 | Xeroderma Pigmentosum | 1.1% |
| 442 | Hypopharyngeal Neoplasms | 1.1% |
| 443 | Pleural Effusion, Malignant | 1.1% |
| 444 | Hypopharyngeal Cancer | 1.1% |
| 445 | Lymphangioleiomyomatosis | 1.1% |
| 446 | Parotid Neoplasms | 1.1% |
| 447 | Prostatic Neoplasms, Castration-Resistant | 1.1% |
| 448 | Nelson Syndrome | 1.1% |
| 449 | Adenofibroma | 1% |
| 450 | Fibroadenoma | 1% |
| 451 | Malignant Fibrous Histiocytoma | 1% |
| 452 | Hodgkin Disease | 1% |
| 453 | Lymphoma, Non-Hodgkin | 1% |
| 454 | Polycystic Ovary Syndrome | 1% |
| 455 | Nasopharyngeal carcinoma | 1% |
| 456 | Hydatidiform Mole | 1% |
| 457 | Astrocytoma | 1% |
| 458 | Ependymoma | 1% |
| 459 | oligodendroglioma | 1% |
| 460 | Ganglioglioma | 1% |
| 461 | gliosarcoma | 1% |
| 462 | Anaplastic astrocytoma | 1% |
| 463 | Anaplastic Oligodendroglioma | 1% |
| 464 | Carcinoma, Endometrioid | 0.9% |
| 465 | Bowen's Disease | 0.9% |
| 466 | Paraganglioma | 0.9% |
| 467 | Rhabdomyosarcoma | 0.9% |
| 468 | Giant Cell Tumor of Bone | 0.9% |
| 469 | Primary amyloidosis | 0.9% |
| 470 | Brain Stem Neoplasms | 0.9% |
| 471 | Malignant Carcinoid Syndrome | 0.9% |
| 472 | Nasopharyngeal Neoplasms | 0.9% |
| 473 | Neurofibrosarcoma | 0.9% |
| 474 | Paranasal Sinus Neoplasms | 0.8% |
| 475 | Adenocarcinoma | 0.8% |
| 476 | Carcinoma in Situ | 0.8% |
| 477 | Carcinoma, Transitional Cell | 0.8% |
| 478 | Phyllodes Tumor | 0.8% |
| 479 | Dysgerminoma | 0.8% |
| 480 | Hemangioendothelioma | 0.8% |
| 481 | Lipoma | 0.8% |
| 482 | Myoma | 0.8% |
| 483 | Myxoma | 0.8% |
| 484 | Neuroma | 0.8% |
| 485 | Papilloma | 0.8% |
| 486 | Pseudomyxoma Peritonei | 0.8% |
| 487 | Seminoma | 0.8% |
| 488 | Papillomatosis | 0.8% |
| 489 | Angiolipoma | 0.8% |
| 490 | Myelolipoma | 0.8% |
| 491 | Neoplasms, Bone Tissue | 0.8% |
| 492 | Neoplasms, Fibrous Tissue | 0.8% |
| 493 | Smooth Muscle Tumor | 0.8% |
| 494 | Adenomatosis, Pulmonary | 0.8% |
| 495 | Adenomatous Polyps | 0.8% |
| 496 | Carcinoma, Large Cell | 0.8% |
| 497 | Carcinoma, Small Cell | 0.8% |
| 498 | Desmoplastic Small Round Cell Tumor | 0.8% |
| 499 | Chondroma | 0.8% |
| 500 | Enchondroma | 0.8% |
| 501 | Tonsillar Neoplasms | 0.8% |
| 502 | Cerebellar Neoplasms | 0.8% |
| 503 | Dermatofibrosarcoma | 0.8% |
| 504 | Dermatofibrosarcoma Protuberans | 0.8% |
| 505 | Glioblastoma | 0.8% |
| 506 | Neuroblastoma | 0.8% |
| 507 | Glioblastoma Multiforme | 0.8% |
| 508 | Choroid Plexus Papilloma | 0.7% |
| 509 | Waldenstrom Macroglobulinemia | 0.7% |
| 510 | Multiple Myeloma | 0.7% |
| 511 | Ganglioneuroblastoma | 0.7% |
| 512 | Leukemia, Myelomonocytic, Chronic | 0.7% |
| 513 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 0.7% |
| 514 | Pheochromocytoma | 0.7% |
| 515 | Alveolar rhabdomyosarcoma | 0.7% |
| 516 | Carcinoid Heart Disease | 0.7% |
| 517 | Mastocytosis | 0.6% |
| 518 | Sturge-Weber Syndrome | 0.6% |
| 519 | Cell Transformation, Viral | 0.6% |
| 520 | Hemangioma, Cavernous | 0.6% |
| 521 | Leukemia, T-Cell | 0.6% |
| 522 | Leukemia, B-Cell | 0.6% |
| 523 | Maxillary Sinus Neoplasms | 0.6% |
| 524 | neurofibroma | 0.6% |
| 525 | Lymphoma, Follicular | 0.6% |
| 526 | T-Cell Lymphoma | 0.6% |
| 527 | Mantle cell lymphoma | 0.6% |
| 528 | Adenoid Cystic Carcinoma | 0.5% |
| 529 | fibroma | 0.5% |
| 530 | Fibromatosis | 0.5% |
| 531 | Osteoblastoma | 0.5% |
| 532 | Osteoma | 0.5% |
| 533 | Rhabdomyoma | 0.5% |
| 534 | Chondromatosis | 0.5% |
| 535 | Adenocarcinoma, Clear Cell | 0.5% |
| 536 | Cholangiocarcinoma | 0.5% |
| 537 | Cervical Intraepithelial Neoplasia | 0.5% |
| 538 | Hemangioblastoma | 0.5% |
| 539 | Lymphoma, Extranodal NK-T-Cell | 0.5% |
| 540 | Mastocytoma | 0.5% |
| 541 | Mastocytosis, Systemic | 0.5% |
| 542 | Leukemia, Myeloid, Chronic-Phase | 0.5% |
| 543 | Fibromatosis, Aggressive | 0.4% |
| 544 | Fibromatosis, Abdominal | 0.4% |
| 545 | Klatskin Tumor | 0.4% |
| 546 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.4% |
| 547 | Leukemia, Large Granular Lymphocytic | 0.4% |
| 548 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.4% |
| 549 | Lymphoma, T-Cell, Cutaneous | 0.4% |
| 550 | Lymphoma, AIDS-Related | 0.4% |
| 551 | Enteropathy-Associated T-Cell Lymphoma | 0.4% |
| 552 | Primary Effusion Lymphoma | 0.4% |
| 553 | Burkitt Lymphoma | 0.3% |
| 554 | Dupuytren Contracture | 0.3% |
| 555 | Urticaria Pigmentosa | 0.3% |
| 556 | Mycosis Fungoides | 0.3% |
| 557 | Lymphomatoid Papulosis | 0.3% |
| 558 | Plasmablastic lymphoma | 0.3% |
| 559 | Sezary Syndrome | 0.2% |
| 560 | Radicular Cyst | 0.2% |